BIOMAT Database Logo BIOMAT Database Logo

N-Acetylation phenotyping with sulfamethazine--problems of sampling. 1989

W Siegmund, and G Franke, and F Kibittel, and R Krüger
Institut of Clinical Pharmacology, Ernst-Moritz-Arndt-University of Greifswald.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013048 Specimen Handling Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. Specimen Collection,Collection, Specimen,Collections, Specimen,Handling, Specimen,Handlings, Specimen,Specimen Collections,Specimen Handlings
D013418 Sulfamethazine A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides. Benzenesulfonamide, 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)-,Sulfadimidine,Sulphamethazine,Sulfadimezine,Sulphamezathine

Related Publications

W Siegmund, and G Franke, and F Kibittel, and R Krüger
N-acetylation phenotyping with sulfamethazine in an Iranian population.
June 1993, Pharmacogenetics,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
N-acetylation phenotyping with sulphadimidine in a Turkish population.
January 1990, European journal of clinical pharmacology,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
N-acetylation phenotyping with dapsone in a mainland Chinese population.
January 1988, British journal of clinical pharmacology,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
N-acetylation phenotyping using dapsone in a Jordanian population.
September 1991, British journal of clinical pharmacology,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
Kinetic discrimination of three sulfamethazine acetylation phenotypes.
January 1980, Clinical pharmacology and therapeutics,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
No effect of smoking on sulfamethazine acetylation.
January 1984, Drug intelligence & clinical pharmacy,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
Acetylation of sulfamethazine in a Nigerian population.
December 1978, Biochemical genetics,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
January 1990, Anticancer research,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
Effect of physical training on sulfamethazine acetylation rate.
December 2000, Bulletin of experimental biology and medicine,
W Siegmund, and G Franke, and F Kibittel, and R Krüger
Induction of sulfamethazine acetylation by hydrocortisone in the rabbit.
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!